EUVIMEDEUVIMED entdecken
Crossref

Based on PI‐RADS v2.1 combining PHI and ADC values to guide prostate biopsy in patients with PSA 4−20 ng/mL

Hua Huang iD, Zihao Liu, Yuan Ma, Yuan Shao, Zhen Yang, Dengyi Duan, Yang Zhao, Simeng Wen, Jing Tian, Yang Liu, Zeyuan Wang, Dan Yue und 1 weitere

The Prostate · 2024-03 · 84 (4) · 376-388

DOI: 10.1002/pros.24658 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Prostate, online erschienen am 20.12.2023. Verfasst von Hua Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Prostate, Prostatic Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Natural Science Foundation of Tianjin, Central Government Guides the Construction of Scientific and Technological Innovation Bases for Local Scientific and Technological Development Funds, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The study aimed to investigate the diagnostic accuracy of prostate health index (PHI) and apparent diffusion coefficient (ADC) values in predicting prostate cancer (PCa) and construct a nomogram for the prediction of PCa and clinically significant PCa (CSPCa) in Prostate Imaging‐Reporting and Data System (PI‐RADS) three lesions cohort.

Methods

This study prospectively enrolled 301 patients who underwent multiparametric magnetic resonance (mpMRI) and were scheduled for prostate biopsy. The receiver operating characteristic curve (ROC) was performed to estimate the diagnostic accuracy of each predictor. Univariable and multivariable logistic regression analysis was conducted to ascertain hidden risk factors and constructed nomograms in PI‐RADS three lesions cohort.

Results

In the whole cohort, the area under the ROC curve (AUC) of PHI is relatively high, which is 0.779. As radiographic parameters, the AUC of PI‐RADS and ADC values was 0.702 and 0.756, respectively. The utilization of PHI and ADC values either individually or in combination significantly improved the diagnostic accuracy of the basic model. In PI‐RADS three lesions cohort, the AUC for PCa was 0.817 in the training cohort and 0.904 in the validation cohort. The AUC for CSPCa was 0.856 in the training cohort and 0.871 in the validation cohort. When applying the nomogram for predicting PCa, 50.0% of biopsies could be saved, supplemented by 6.9% of CSPCa being missed.

Conclusion

PHI and ADC values can be used as predictors of CSPCa. The nomogram included PHI, ADC values and other clinical predictors demonstrated an enhanced capability in detecting PCa and CSPCa within PI‐RADS three lesions cohort.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstateProstatic NeoplasmsMaleHumansMagnetic Resonance ImagingProstate-Specific AntigenRetrospective StudiesBiopsy

Stichwörter der Autor:innen

ADC valuesPI-RADSnomogramprostate cancerprostate health index

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Department of Radiology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • School of Medical Laboratory, Tianjin Medical University, Tianjin, China.

ORCID-Profile: Hua Huang

Förderung

  • Natural Science Foundation of Tianjin
  • Central Government Guides the Construction of Scientific and Technological Innovation Bases for Local Scientific and Technological Development Funds
  • National Natural Science Foundation of China
  • Key Program of Tianjin Municipal Education Commission
  • Tianjin Health Research Project
  • Science and Technology Program of Tianjin

Zitieren

APA

Huang, H., Liu, Z., Ma, Y., Shao, Y., Yang, Z., Duan, D., Zhao, Y., Wen, S., Tian, J., Liu, Y., Wang, Z., Yue, D., & Wang, Y. (2024). Based on PI‐RADS v2.1 combining PHI and ADC values to guide prostate biopsy in patients with PSA 4−20 ng/mL. The Prostate, 84(4), 376-388. https://doi.org/10.1002/pros.24658

Vancouver

Huang H, Liu Z, Ma Y, Shao Y, Yang Z, Duan D, et al. Based on PI‐RADS v2.1 combining PHI and ADC values to guide prostate biopsy in patients with PSA 4−20 ng/mL. The Prostate. 2024;84(4):376-388. doi:10.1002/pros.24658

BibTeX
@article{Huang2024,
  author = {Huang, Hua and Liu, Zihao and Ma, Yuan and Shao, Yuan and Yang, Zhen and Duan, Dengyi and Zhao, Yang and Wen, Simeng and Tian, Jing and Liu, Yang and Wang, Zeyuan and Yue, Dan and Wang, Yong},
  title = {Based on PI‐RADS v2.1 combining PHI and ADC values to guide prostate biopsy in patients with PSA 4−20 ng/mL},
  journal = {The Prostate},
  year = {2024},
  volume = {84},
  number = {4},
  pages = {376--388},
  doi = {10.1002/pros.24658}
}
Kostenlos starten →